Flurpiridaz F-18 PET Myocardial Perfusion Imaging in Patients With Suspected Coronary Artery Disease

By sjmartinez • October 12, 2023

Maddahi J, Agostini D, Bateman TM, Bax JJ, Beanlands RSB, Berman DS, Dorbala S, Garcia EV, Feldman J, Heller GV, Knuuti JM, Martinez-Clark P, Pelletier-Galarneau M, Shepple B, Tamaki N, Tranquart F, Udelson JE. Flurpiridaz F-18 PET Myocardial Perfusion Imaging in Patients With Suspected Coronary Artery Disease. J Am Coll Cardiol. 2023 Oct 17;82(16):1598-1610. doi: 10.1016/j.jacc.2023.08.016. PMID: 37821170.

Tags: Cardiology/Epi, coronary artery disease, flurpiridaz, myocardial perfusion imaging, phase 3 PET trial, Positron emission tomography, Publications

Diabetic Cardiomyopathy: What Clinicians Should Know

Smati H, Qadeer YK, Rodriguez M, Moras E, Fonarow GC, Isaacs SD, Marwick TH, Krittanawong C. Diabetic Cardiomyopathy: What Clinicians Should Know. Am J Med.[...]

Heart Failure With Preserved Ejection Fraction-A Role for Invasive Hemodynamics

Fonarow GC, Udelson JE, Yancy CW. Heart Failure With Preserved Ejection Fraction-A Role for Invasive Hemodynamics. JAMA Cardiol. 2024 Nov 6. doi: 10.1001/jamacardio.2024.3764. Epub ahead[...]

Stakeholder Perspectives on a Heart Failure With Reduced Ejection Fraction Polypill: A Multi-Center Mixed Methods Study

Chen JC, DeJong C, Agarwal M, Hairston AM, Durstenfeld MS, McKay V, Huffman MD, Hsue PY, Agarwal A. Stakeholder Perspectives on a Heart Failure With[...]